Impedimed
0
Product was successfully added to your cart
  • About
    • Careers
    • Contact Us
  • Technology
    • Patents
  • Newsroom
    • News
    • Events
  • Products
  • Support
    • Knowledge Center
      • What is L-Dex® ?
      • Medical Applications
        • Lymphedema
          • Managing Lymphedema
        • Fluid Status/Body Composition
        • Research
      • Physician Resources
        • Dr. Stanley G. Rockson Video Q&A
        • Dr. McGarvey addresses questions
      • Health Insurance Providers
        • Pre-emptive Versus Reactive Models of Care
        • Informational Videos
        • FAQ From Health Insurance Providers
      • Published Papers & Clinical References
        • Lymphedema Data
        • Body Composition
        • Research: Veterinary BIS
      • Medical Glossary
      • FAQs
        • FAQ From Health Insurance Providers
    • Customer Support
      • Return Request
      • L-Dex Providers
      • Request a Quote
      • Register product
      • Technical Support
    • Quality and Regulatory Certifications
  • Investors

Category: News

Home Archive by Category "News"

Medical Advisory Board for Chronic Heart Failure Established

January 11, 2016NewsCardiology, News

Brisbane, Australia and Carlsbad, CA – ImpediMed Limited (ASX: IPD) a global provider of medical technology to measure, monitor and manage fluid status and body composition, announced today that it has entered into agreements to establish a Medical Advisory Board to advise the Company on the design of clinical trials for the use of bioimpedance…

Read More

Medical Advisory Board per la cronica insufficienza cardiaca Fondata

January 11, 2016NewsCardiology, News

Brisbane, Australia e Carlsbad, CA – ImpediMed Limited (ASX: IPD) un fornitore globale di tecnologia medica di misurare, controllare e gestire lo stato liquido e la composizione corporea, ha annunciato oggi di aver stipulato accordi per stabilire una Medical Advisory Board di consigliare la Società sulla progettazione di studi clinici per l’uso della spettroscopia bioimpedenza…

Read More

ImpediMed Announces U.S. Commercial Launch of L-Dex® System for Assessment of Lymphedema in Cancer Survivors

January 7, 2016NewsNews, Oncology

CARLSBAD, CA, January 7, 2016 – ImpediMed Limited (ASX: IPD), a global provider of medical technology to measure, monitor and manage fluid status in patients, has announced the U.S. commercial launch of its L-Dex® system to aid in the clinical assessment of lymphedema. This follows a successful pilot program involving six U.S. cancer centers, a…

Read More

ImpediMed annuncia US lancio commerciale di L-Dex® sistema per la valutazione del linfedema nei sopravvissuti al cancro

January 7, 2016NewsNews, Oncology

CARLSBAD, CA, 7 GENNAIO 2016 – ImpediMed Limited (ASX: IPD), fornitore globale di tecnologia medica di misurare, controllare e gestire lo stato idrica in pazienti, ha annunciato il lancio commerciale degli Stati Uniti del suo sistema L-Dex® per aiutare nella la valutazione clinica del linfedema. Questo segue un programma pilota di successo che coinvolge sei…

Read More

Lymphoedema included in ACS/ASCO Breast Cancer Survivorship Care Guideline

December 9, 2015NewsNews, Oncology

Brisbane, Australia – ImpediMed (ASX: IPD) is pleased to announce that the first joint American Cancer Society (ACS)/American Society of Clinical Oncology (ASCO) Breast Cancer Survivorship Care Guideline has now been published in the Journal of Clinical Oncology. The guideline recommends clinicians to focus on the early identification and management of lymphoedema and counsel survivors…

Read More

Linfedema incluso in ACS / ASCO Breast Cancer Survivorship Cura Guideline

December 9, 2015NewsNews, Oncology

Brisbane, Australia – ImpediMed (ASX: IPD) è lieta di annunciare che il primo giunto American Cancer Society (ACS) / American Society of Clinical Oncology (ASCO) Breast Cancer Survivorship Cura Direttiva è stata ora pubblicata sul Journal of Clinical Oncology. La linea guida raccomanda ai medici di concentrarsi sulla individuazione precoce e la gestione del linfedema…

Read More

Harvard Clinical Research Institute Agreement

November 3, 2015NewsCardiology, News

Brisbane, Australia – ImpediMed Limited (ASX: IPD) a leading provider of technology to measure, monitor and manage fluid status and body composition, announced today that it has entered into an agreement with the prestigious Harvard Clinical Research Institute (HCRI) located in Boston, Massachusetts, to advance research around the use of bioimpedance spectroscopy (BIS) in fluid…

Read More

Harvard Clinical Research Institute Accordo

November 3, 2015News

Brisbane, Australia – ImpediMed Limited (ASX: IPD), un fornitore leader di tecnologia per misurare, monitorare e gestire lo stato liquido e la composizione corporea, ha annunciato oggi di aver stipulato un accordo con la prestigiosa Harvard Clinical Research Institute (HCRI) che si trova a Boston , Massachusetts, per far avanzare la ricerca intorno all’uso della…

Read More

ImpediMed Announces Purchase of Key Assets and Intellectual Property

October 26, 2015NewsNews

Brisbane, Australia – ImpediMed Limited (ASX: IPD) (“The Company”), a leading provider of technology to measure, monitor and manage fluid status and body composition, today announced that it has acquired certain key assets and intellectual property from Intersection Medical Incorporated. The purchase includes all rights, title, and interest in bioimpedance spectroscopy and other associated technology…

Read More

ImpediMed annuncia acquisti di attività chiave e proprietà intellettuale

October 26, 2015NewsNews

Brisbane, Australia – ImpediMed Limited (ASX: IPD) (“The Company”), a leading provider of technology to measure, monitor and manage fluid status and body composition, today announced that it has acquired certain key assets and intellectual property from Intersection Medical Incorporated. The purchase includes all rights, title, and interest in bioimpedance spectroscopy and other associated technology…

Read More

Recent Posts

  • Medical Advisory Board for Chronic Heart Failure Established
  • Medical Advisory Board per la cronica insufficienza cardiaca Fondata
  • ImpediMed Announces U.S. Commercial Launch of L-Dex® System for Assessment of Lymphedema in Cancer Survivors
  • ImpediMed annuncia US lancio commerciale di L-Dex® sistema per la valutazione del linfedema nei sopravvissuti al cancro
  • Lymphoedema included in ACS/ASCO Breast Cancer Survivorship Care Guideline
  • Contact Us
  • quality
  • Newsroom
  • Investors
  • Legal & IP
  • Terms of Use
  • Privacy Policy
  • Careers
© 2016 - 2019 All rights reserved. ImpediMed Ltd and ImpediMed Inc.